Information Provided By: 
Fly News Breaks for November 12, 2015
HOLX
Nov 12, 2015 | 08:00 EDT
UBS continues to think Hologic is in the early days of realizing significant operational improvements and that the improvements are not yet fully reflected in the stock. The firm sees consensus estimates trending higher over the next 12 months and believes the company has many levers to pull to continue to improve returns for shareholders. UBS reiterated its Buy rating and $45 price target on Hologic shares.
News For HOLX From the Last 2 Days
There are no results for your query HOLX
